These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35320283)

  • 21. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of CD137 signaling promotes neointimal formation by attenuating TET2 and transferrring from endothelial cell-derived exosomes to vascular smooth muscle cells.
    Li B; Zang G; Zhong W; Chen R; Zhang Y; Yang P; Yan J
    Biomed Pharmacother; 2020 Jan; 121():109593. PubMed ID: 31766102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.
    Choe N; Kwon JS; Kim YS; Eom GH; Ahn YK; Baik YH; Park HY; Kook H
    Cell Signal; 2015 Jun; 27(6):1056-65. PubMed ID: 25683915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomere damage promotes vascular smooth muscle cell senescence and immune cell recruitment after vessel injury.
    Uryga AK; Grootaert MOJ; Garrido AM; Oc S; Foote K; Chappell J; Finigan A; Rossiello F; d'Adda di Fagagna F; Aravani D; Jorgensen HF; Bennett MR
    Commun Biol; 2021 May; 4(1):611. PubMed ID: 34021256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular Smooth Muscle Cell Senescence Promotes Atherosclerosis and Features of Plaque Vulnerability.
    Wang J; Uryga AK; Reinhold J; Figg N; Baker L; Finigan A; Gray K; Kumar S; Clarke M; Bennett M
    Circulation; 2015 Nov; 132(20):1909-19. PubMed ID: 26416809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M2 macrophage-derived exosomes promote the c-KIT phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation.
    Yan W; Li T; Yin T; Hou Z; Qu K; Wang N; Durkan C; Dong L; Qiu J; Gregersen H; Wang G
    Theranostics; 2020; 10(23):10712-10728. PubMed ID: 32929376
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of lysine-specific demethylase 1A suppresses neointimal hyperplasia by targeting bone morphogenetic protein 2 and mediating vascular smooth muscle cell phenotype.
    Zhang X; Huang T; Zhai H; Peng W; Zhou Y; Li Q; Yang H
    Cell Prolif; 2020 Jan; 53(1):e12711. PubMed ID: 31737960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mining the Stiffness-Sensitive Transcriptome in Human Vascular Smooth Muscle Cells Identifies Long Noncoding RNA Stiffness Regulators.
    Yu CK; Xu T; Assoian RK; Rader DJ
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):164-173. PubMed ID: 29051139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MIA SH3 Domain ER Export Factor 3 Deficiency Prevents Neointimal Formation by Restoring BAT-Like PVAT and Decreasing VSMC Proliferation and Migration.
    Lei Y; Xu J; Li M; Meng T; Chen M; Yang Y; Li H; Zhuang T; Zuo J
    Front Endocrinol (Lausanne); 2021; 12():748216. PubMed ID: 34858331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulforaphane inhibits PDGF-induced proliferation of rat aortic vascular smooth muscle cell by up-regulation of p53 leading to G1/S cell cycle arrest.
    Yoo SH; Lim Y; Kim SJ; Yoo KD; Yoo HS; Hong JT; Lee MY; Yun YP
    Vascul Pharmacol; 2013; 59(1-2):44-51. PubMed ID: 23810908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100B promotes injury-induced vascular remodeling through modulating smooth muscle phenotype.
    Cao T; Zhang L; Yao LL; Zheng F; Wang L; Yang JY; Guo LY; Li XY; Yan YW; Pan YM; Jiang M; Chen L; Tang JM; Chen SY; Wang JN
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2772-2782. PubMed ID: 28693920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal Hyperplasia.
    Yue H; Febbraio M; Klenotic PA; Kennedy DJ; Wu Y; Chen S; Gohara AF; Li O; Belcher A; Kuang B; McIntyre TM; Silverstein RL; Li W
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):263-275. PubMed ID: 30567481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway.
    Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X
    Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. THO Complex-Dependent Posttranscriptional Control Contributes to Vascular Smooth Muscle Cell Fate Decision.
    Yuan X; Zhang T; Yao F; Liao Y; Liu F; Ren Z; Han L; Diao L; Li Y; Zhou B; He F; Wang L
    Circ Res; 2018 Aug; 123(5):538-549. PubMed ID: 30026254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.
    van der Veer EP; de Bruin RG; Kraaijeveld AO; de Vries MR; Bot I; Pera T; Segers FM; Trompet S; van Gils JM; Roeten MK; Beckers CM; van Santbrink PJ; Janssen A; van Solingen C; Swildens J; de Boer HC; Peters EA; Bijkerk R; Rousch M; Doop M; Kuiper J; Schalij MJ; van der Wal AC; Richard S; van Berkel TJ; Pickering JG; Hiemstra PS; Goumans MJ; Rabelink TJ; de Vries AA; Quax PH; Jukema JW; Biessen EA; van Zonneveld AJ
    Circ Res; 2013 Oct; 113(9):1065-75. PubMed ID: 23963726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of M3AChR (Type 3 Muscarinic Acetylcholine Receptor) and Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling by Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching and Vascular Remodeling.
    He X; Deng J; Yu XJ; Yang S; Yang Y; Zang WJ
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2649-2664. PubMed ID: 32938216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Pathological Role of hnRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1) in Vascular Smooth Muscle Cell Function and Neointima Hyperplasia.
    Zhang L; Chen Q; An W; Yang F; Maguire EM; Chen D; Zhang C; Wen G; Yang M; Dai B; Luong LA; Zhu J; Xu Q; Xiao Q
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2182-2194. PubMed ID: 28912364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.
    Reddy MA; Das S; Zhuo C; Jin W; Wang M; Lanting L; Natarajan R
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):864-73. PubMed ID: 26941017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.